F2-Isoprostanes

"F2-Isoprostanes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Isoprostanes derived from the free radical oxidation of ARACHIDONIC ACID. Although similar in structure to enzymatically synthesized prostaglandin F2alpha (DINOPROST), they occur through non-enzymatic oxidation of cell membrane lipids.

Descriptor ID	D028441
MeSH Number(s)	D10.251.355.255.100.375.500 D10.251.355.310.166.775.500 D10.251.355.411.500
Concept/Terms	F2-Isoprostanes F2-Isoprostanes F2 Isoprostanes F2-Isoprostane F2 Isoprostane

Below are MeSH descriptors whose meaning is more general than "F2-Isoprostanes".

Chemicals and Drugs [D]
Lipids [D10]
Fatty Acids [D10.251]
Fatty Acids, Unsaturated [D10.251.355]
Eicosanoids [D10.251.355.255]
Arachidonic Acids [D10.251.355.255.100]
Isoprostanes [D10.251.355.255.100.375]
F2-Isoprostanes [D10.251.355.255.100.375.500]
Fatty Acids, Essential [D10.251.355.310]
Arachidonic Acids [D10.251.355.310.166]
Isoprostanes [D10.251.355.310.166.775]
F2-Isoprostanes [D10.251.355.310.166.775.500]
Isoprostanes [D10.251.355.411]
F2-Isoprostanes [D10.251.355.411.500]

Below are MeSH descriptors whose meaning is related to "F2-Isoprostanes".

Below are MeSH descriptors whose meaning is more specific than "F2-Isoprostanes".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "F2-Isoprostanes" by people in this website by year, and whether "F2-Isoprostanes" was a major or minor topic of these publications.

Bar chart showing 14 publications over 9 distinct years, with a maximum of 5 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2001	1	0	1
2003	0	1	1
2004	0	1	1
2007	0	1	1
2009	2	3	5
2011	1	0	1
2012	1	1	2
2015	0	1	1

Below are the most recent publications written about "F2-Isoprostanes" by people in Profiles.

Morimoto Y, Beckford F, Cooney RV, Franke AA, Maskarinec G. Adherence to cancer prevention recommendations and antioxidant and inflammatory status in premenopausal women. Br J Nutr. 2015 Jul 14; 114(1):134-43.

View in: PubMed
Dorjgochoo T, Gao YT, Chow WH, Shu XO, Yang G, Cai Q, Rothman N, Cai H, Li H, Deng X, Franke A, Roberts LJ, Milne G, Zheng W, Dai Q. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself. Am J Clin Nutr. 2012 Aug; 96(2):405-14.

View in: PubMed
Harrison FE, Best JL, Meredith ME, Gamlin CR, Borza DB, May JM, May JM. Increased expression of SVCT2 in a new mouse model raises ascorbic acid in tissues and protects against paraquat-induced oxidative damage in lung. PLoS One. 2012; 7(4):e35623.

View in: PubMed
Jamil J, Wright A, Harrison N, Kegey E, Flowers AF, Flyod NJ, Kotera C, Guy A, Galano JM, Durand T, Njie-Mbye YF, Ohia SE, Opere CA. Regulation of [?H]d-aspartate release by the 5-F(2t)-isoprostane and its 5-epimer in isolated bovine retina. Neurochem Res. 2012 Mar; 37(3):574-82.

View in: PubMed
Wang Z, Yang H, Ramesh A, Roberts LJ, Zhou L, Lin X, Zhao Y, Guo Z. Overexpression of Cu/Zn-superoxide dismutase and/or catalase accelerates benzo(a)pyrene detoxification by upregulation of the aryl hydrocarbon receptor in mouse endothelial cells. Free Radic Biol Med. 2009 Oct 15; 47(8):1221-9.

View in: PubMed
Sood A, Qualls C, Arynchyn A, Beckett WS, Gross MD, Steffes MW, Smith LJ, Holvoet P, Thyagarajan B, Jacobs DR. Obesity-asthma association: is it explained by systemic oxidant stress? Chest. 2009 Oct; 136(4):1055-1062.

View in: PubMed
Epplein M, Franke AA, Cooney RV, Morris JS, Wilkens LR, Goodman MT, Murphy SP, Henderson BE, Kolonel LN, Le Marchand L. Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):1962-70.

View in: PubMed
Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, Chen D, Weinstein J, Shore J, da Silva B, Belsey E, McComsey GA, Murphy RL. Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. J Antimicrob Chemother. 2009 Jun; 63(6):1244-50.

View in: PubMed
Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control. 2009 Sep; 20(7):1161-71.

View in: PubMed
Akohoue SA, Shankar S, Milne GL, Morrow J, Chen KY, Ajayi WU, Buchowski MS. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007 Feb; 61(2):233-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals